158 related articles for article (PubMed ID: 32956122)
1. 18F-FDG PET/CT Helps Differentiate Peripheral Nerve Myeloid Sarcoma From a Presumed Benign Nerve Sheath Tumor.
Das JP; Riedl CC; Ulaner GA
Clin Nucl Med; 2020 Dec; 45(12):989-991. PubMed ID: 32956122
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
[TBL] [Abstract][Full Text] [Related]
3. Potential role of 18fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating benign neurofibroma from malignant peripheral nerve sheath tumor associated with neurofibromatosis 1.
Karabatsou K; Kiehl TR; Wilson DM; Hendler A; Guha A
Neurosurgery; 2009 Oct; 65(4 Suppl):A160-70. PubMed ID: 19927062
[TBL] [Abstract][Full Text] [Related]
4. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
[TBL] [Abstract][Full Text] [Related]
5. 18F-FDG PET/CT Imaging of Testicular Myeloid Sarcoma in a Pediatric Patient.
Wu J; Jiang G; Wu J; Ou L; Zhang C
Clin Nucl Med; 2021 Jan; 46(1):84-85. PubMed ID: 33181756
[TBL] [Abstract][Full Text] [Related]
6. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
Salamon J; Mautner VF; Adam G; Derlin T
Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
[TBL] [Abstract][Full Text] [Related]
7. Plurifocal malignant peripheral nerve sheath tumor demonstrated by 18F-fluorodeoxyglucose positron emission tomography/computed tomography.
Bertagna F; Bosio G; Biasiotto G; Savelli G; Rodella C; Giubbini R; Rosenbaum J; Alavi A
Jpn J Radiol; 2009 Oct; 27(8):320-3. PubMed ID: 19856228
[TBL] [Abstract][Full Text] [Related]
8. Retroperitoneal malignant peripheral nerve sheath tumor: evaluation with serial FDG-PET.
Chander S; Westphal SM; Zak IT; Bloom DA; Zingas AP; Joyrich RN; Littrup PJ; Taub JW; Getzen TM
Clin Nucl Med; 2004 Jul; 29(7):415-8. PubMed ID: 15192465
[TBL] [Abstract][Full Text] [Related]
9. Malignant Peripheral Nerve Sheath Tumor Arising From Transplanted Kidney Assessed by 18F-FDG PET/CT.
Feng H; Tu N; Bu L
Clin Nucl Med; 2020 Nov; 45(11):905-907. PubMed ID: 32969901
[TBL] [Abstract][Full Text] [Related]
10. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
Chirindel A; Chaudhry M; Blakeley JO; Wahl R
J Nucl Med; 2015 Mar; 56(3):379-85. PubMed ID: 25655626
[TBL] [Abstract][Full Text] [Related]
11. 18 F-FDG PET/CT Findings of Myeloid Sarcoma Involving the Left Ventricle and Kidney in a Pediatric Patient.
Zhang M; Yang X; Si Y; Kan Y; Yang J
Clin Nucl Med; 2023 Jan; 48(1):103-105. PubMed ID: 36179330
[TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of 18F-FDG PET/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
Derlin T; Tornquist K; Münster S; Apostolova I; Hagel C; Friedrich RE; Wedegärtner U; Mautner VF
Clin Nucl Med; 2013 Jan; 38(1):e19-25. PubMed ID: 23242059
[TBL] [Abstract][Full Text] [Related]
13. Imaging of non-neurogenic peripheral nerve malignancy-a case series and systematic review.
Luna R; Fayad LM; Rodriguez FJ; Ahlawat S
Skeletal Radiol; 2021 Jan; 50(1):201-215. PubMed ID: 32699955
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET/CT and MRI findings in a case of granulocytic sarcoma of the breast.
Otsuka Y; Kondo T; Nakamoto Y; Haga H; Takaori-Kondo A
Int J Hematol; 2016 Feb; 103(2):117-8. PubMed ID: 26692195
[No Abstract] [Full Text] [Related]
15. 18-fluorodeoxyglucose-positron emission tomography (FDG-PET) evaluation of nodular lesions in patients with Neurofibromatosis type 1 and plexiform neurofibromas (PN) or malignant peripheral nerve sheath tumors (MPNST).
Meany H; Dombi E; Reynolds J; Whatley M; Kurwa A; Tsokos M; Salzer W; Gillespie A; Baldwin A; Derdak J; Widemann B
Pediatr Blood Cancer; 2013 Jan; 60(1):59-64. PubMed ID: 22645095
[TBL] [Abstract][Full Text] [Related]
16. 18F-FDG PET/CT and 68Ga-DOTA-FAPI-04 PET/CT Findings of Myeloid Sarcoma.
Liu W; Yang X; Chen L; Chen Y; Xu T
Clin Nucl Med; 2023 Mar; 48(3):278-279. PubMed ID: 36723889
[TBL] [Abstract][Full Text] [Related]
17. Myeloid sarcoma presenting as an anterior mediastinal mass invading the pericardium: Serial Imaging With F-18 FDG PET/CT.
Makis W; Hickeson M; Derbekyan V
Clin Nucl Med; 2010 Sep; 35(9):706-9. PubMed ID: 20706048
[TBL] [Abstract][Full Text] [Related]
18. False-negative fluorine-18 fluorodeoxyglucose positron emission tomography of a malignant peripheral nerve sheath tumor arising from a plexiform neurofibroma in the setting of neurofibromatosis type 1.
Shahid KR; Amrami KK; Esther RJ; Lowe VJ; Spinner RJ
J Surg Orthop Adv; 2011; 20(2):132-5. PubMed ID: 21838076
[TBL] [Abstract][Full Text] [Related]
19. Use of 68Ga-FAPI PET/CT for Detecting Myeloid Sarcoma of the Breast and Assessing Early Response to Chemotherapy.
Wu S; Lin Z; Shang Q; Pang Y; Chen H
Clin Nucl Med; 2022 Jun; 47(6):549-550. PubMed ID: 35025784
[TBL] [Abstract][Full Text] [Related]
20. FDG PET/CT Findings of Intracardiac Myeloid Sarcoma.
Niu N; Cui R; Li F
Clin Nucl Med; 2016 Mar; 41(3):235-6. PubMed ID: 26505855
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
